1. Home
  2. MRKR vs SFHG Comparison

MRKR vs SFHG Comparison

Compare MRKR & SFHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRKR
  • SFHG
  • Stock Information
  • Founded
  • MRKR N/A
  • SFHG 1993
  • Country
  • MRKR United States
  • SFHG Hong Kong
  • Employees
  • MRKR N/A
  • SFHG N/A
  • Industry
  • MRKR Biotechnology: Pharmaceutical Preparations
  • SFHG Publishing
  • Sector
  • MRKR Health Care
  • SFHG Consumer Discretionary
  • Exchange
  • MRKR Nasdaq
  • SFHG Nasdaq
  • Market Cap
  • MRKR 19.1M
  • SFHG 16.2M
  • IPO Year
  • MRKR N/A
  • SFHG 2024
  • Fundamental
  • Price
  • MRKR $1.47
  • SFHG $0.72
  • Analyst Decision
  • MRKR Strong Buy
  • SFHG
  • Analyst Count
  • MRKR 3
  • SFHG 0
  • Target Price
  • MRKR $13.17
  • SFHG N/A
  • AVG Volume (30 Days)
  • MRKR 231.4K
  • SFHG 45.7K
  • Earning Date
  • MRKR 08-13-2025
  • SFHG 07-07-2025
  • Dividend Yield
  • MRKR N/A
  • SFHG N/A
  • EPS Growth
  • MRKR N/A
  • SFHG N/A
  • EPS
  • MRKR N/A
  • SFHG N/A
  • Revenue
  • MRKR $5,696,123.00
  • SFHG $19,760,935.00
  • Revenue This Year
  • MRKR N/A
  • SFHG N/A
  • Revenue Next Year
  • MRKR $11.28
  • SFHG N/A
  • P/E Ratio
  • MRKR N/A
  • SFHG N/A
  • Revenue Growth
  • MRKR 71.53
  • SFHG 30.89
  • 52 Week Low
  • MRKR $0.95
  • SFHG $0.55
  • 52 Week High
  • MRKR $5.99
  • SFHG $24.00
  • Technical
  • Relative Strength Index (RSI)
  • MRKR 50.81
  • SFHG N/A
  • Support Level
  • MRKR $1.41
  • SFHG N/A
  • Resistance Level
  • MRKR $1.53
  • SFHG N/A
  • Average True Range (ATR)
  • MRKR 0.16
  • SFHG 0.00
  • MACD
  • MRKR -0.03
  • SFHG 0.00
  • Stochastic Oscillator
  • MRKR 9.43
  • SFHG 0.00

About MRKR Marker Therapeutics Inc.

Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets.

About SFHG Samfine Creation Holdings Group Limited Ordinary Share

Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.

Share on Social Networks: